ALA

0.00%

15.5¢ arovella therapeutics limited

hey von if they get rid of Mr Carter, appoint a new chairman and...

First 116 Last

Share
Profile

Follow
pogues

5,853 Posts.

809

14/05/19

15:37

Post #: 38558803
Share

Originally posted by vontrader: ↑

So safe to say this turned out to be bologna ?

"YOu and I know that this info doesnt get disclosed Von. As Mr Carter told the crew at AGM Strides pays Suda $170 k per month in development fees and ZLD will possibly pay another $100k circa per month. Suddenly we reach a cash neutral territory inside the lab and de-risk the investment significantly. Get on board Von and stop your complaining. Get your twitter account running and get your army of followers buying!"

Punters here were categorically telling people that they heard from Carter at the AGM SUD would receive up to $270K per month in development fees. I challenged this at the time as hogwash, as it wasn't public and never once been referenced in an announcement.

The latest 4c certainly does show $1M of royalties for the quarter

Now the latest rumor doing the rounds on Twitter, care of @MSmallcap

"Talk is some very large pharma deals to land which will be fully funded all the way to market by the counter party. It could be as many as 3-4 and expect a few to have landed in the coming weeks. A re-rate in the coming weeks which should be multiples. Ive been targeting the oppies"

Why is everything Chinese whispers, where you have to call Carter or this person and it's all hush hush. If any of this was legitimate, it would be announced via the ASX publicly

The best thing for SUD would be to fire the Chairman on $350K p.a, get a new management team, stop trying to have their fingers in 10 different pies at once and just seek to develop 1 flagship asset with a decent upfront commitment

What good is having 5-10 different lots of IP, where none of which deliver anything worthwhile upfront, all have 12-24 month development lead times and no immediately achievable large milestone payments ?

Expand

hey von if they get rid of Mr Carter, appoint a new chairman and focus - are you going to fire up the vontrain again?

SUD Price at posting: 0.4¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 18 more messages in this thread...

First 116 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change 0.000(0.00%)		Mkt cap ! $163.0M

Open	High	Low	Value	Volume
15.5¢	15.8¢	15.0¢	$198.5K	1.280M

Buyers (Bids)

No.	Vol.	Price($)
15	438029	15.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	283200	1

View Market Depth

No.	Vol.	Price($)
14	410529	0.150
9	272672	0.145
7	454047	0.140
4	383000	0.135
4	111077	0.130

Price($)	Vol.	No.
0.155	283200	1
0.160	222494	4
0.165	546319	9
0.170	930681	12
0.175	890346	10

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ALA (ASX) Chart

hey von if they get rid of Mr Carter, appoint a new chairman and...

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

hey von if they get rid of Mr Carter, appoint a new chairman and...

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News